companydata.dkcompanydata.dk

TFS TRIAL FORM SUPPORT ApS: Financial statements 2019

CVR: 10064627

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

TFS TRIAL FORM SUPPORT ApS (CVR 10064627) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 16,839,583 and a net result of DKK -1,192,921 compared with DKK -188,800 the year before. That is an increase of 10.1% compared with the year before. Equity in the 2019 report amounted to DKK 4,982,550. The solvency ratio was 32.3%. The company had 25 employees in the financial year.

Gross Profit
DKK 16,839,583
Profit/Loss
DKK -1,192,921
Equity
DKK 4,982,550
Total Assets
DKK 15,446,298
Employees
25

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-16.8 mio.-1.2 mio.5 mio.25
2018-15.3 mio.-189 t.6.2 mio.25
2017-15.5 mio.1 mio.6.4 mio.21
2016-13.8 mio.445 t.5.3 mio.-
2015-14.8 mio.463 t.4.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

TFS TRIAL FORM SUPPORT ApS: The 2018 annual report is outJun 8, 2019

TFS TRIAL FORM SUPPORT ApS has published its annual report for 2018. Gross profit came to DKK 15,297,804, and the net result was DKK -188,800.

Lars Gunnar Tordson Wadell joins the board of TFS TRIAL FORM SUPPORT ApSMay 2, 2019

As of May 2, 2019, Lars Gunnar Tordson Wadell has joined the board of directors of TFS TRIAL FORM SUPPORT ApS.

Ryan Shortreed leaves the board of TFS TRIAL FORM SUPPORT ApSMay 2, 2019

As of May 2, 2019, Ryan Shortreed has left the board of directors of TFS TRIAL FORM SUPPORT ApS.

About TFS TRIAL FORM SUPPORT ApS

TFS TRIAL FORM SUPPORT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2001. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jan Markus Granlund. The board consists of Jesper Hjort (chair) and Jan Markus Granlund. The company is owned by TFS International Clinical Development Services AB. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 8,921,130 and a net result of DKK -845,854 compared with DKK -1,834,180 the year before. Equity in the 2025 report amounted to DKK 1,750,487.

Source: annual report 2025, Danish Business Authority